Djokovic has 80% stake in biotech firm developing Covid drug

QuantBioRes is working on a treatment not a vaccine, but CEO says tennis star is not anti-vax'

Novak Djokovic is the controlling shareholder in a Danish biotech firm aiming to develop a treatment for Covid-19 that does not involve vaccination, it has emerged.

The world No 1, who was deported from Australia this week after the government cancelled his visa in a dispute over a medical exemption relating to his unvaccinated status, bought an 80% stake in QuantBioRes in 2020.